化学科研者一站式服务平台


  • 2-(1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基)-1-吗啉乙酮

    2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone

化合物简介

BML-190 (Indomethacin morpholinylamide) is a drug used in scientific research that acts as a selective CB2 inverse agonist. BML-190 is structurally derived from the NSAID indomethacin but has a quite different biological activity. The activity produced by this compound is disputed, with some sources referring to it as a CB2 agonist rather than an inverse agonist; this may reflect an error in classification, or alternatively it may produce different effects in different tissues, and more research is required to resolve this dispute.

基本信息

CAS:2854-32-2
中文别名:2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基]-1-(4-吗啉基)乙酮;
英文别名:Lopac-I-151;Indomethacin Morpholinylamide;Tocris-1383;Indomethacin morpholinamide;Indomethacin morpholinylamide;2-Methyl-5-methoxy-3-indolyl-essigsaeure-amid;IMMA;Ethanone (2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl);BML-190;
分子式:C23H23ClN2O4
分子量:426.893
精确质量:426.135
Psa:60.77
Logp:3.6394

编号系统

MDL号:MFCD01317813

物化性质

密度:1.31g/cm3
沸点:586.7ºC at 760mmHg
闪点:308.6ºC
折射率:1.624
储存条件:2-8ºC
蒸汽压:8.34E-17mmHg at 25°C

安全信息

WGK Germany:3
海关编码:2934999090

生产方法及用途

合成路线

上游原料

下游产品

图谱

Predict 1H proton NMR


加载中...